Stay updated on Pembrolizumab Post-TACE in Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Post-TACE in Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Post-TACE in Liver Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page's revision tag in the footer updated from v3.6.5 to v3.6.6, indicating a new build of the site. This behind-the-scenes update is related to the page version and does not modify the study details.
    Difference
    0.1%
    Check dated 2026-09-02T19:37:34.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page shows a revised revision label, updating from v3.6.4 to v3.6.5 to reflect a minor backend update to the site.
    Difference
    0.1%
    Check dated 2026-08-12T09:27:20.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.4, replacing the prior Revision: v3.6.3, indicating an updated site or document version.
    Difference
    0.1%
    Check dated 2026-07-28T15:40:40.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Revision: v3.6.3 was added and the previous Revision: v3.6.0 was removed. This indicates the page's version was updated.
    Difference
    0.1%
    Check dated 2026-06-30T01:17:17.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Recruitment status is updated to indicate that no participants are being sought. The page also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment heading, along with a revision update from v3.5.5 to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-15T19:09:04.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Revision indicator updated from v3.5.4 to v3.5.5, signaling a small update to the page’s underlying version. This change reflects an internal patch or improvement rather than a modification to the study content.
    Difference
    0.1%
    Check dated 2026-06-08T15:19:35.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Post-TACE in Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Post-TACE in Liver Cancer Clinical Trial page.